Antifungal Agents Market Size | COVID-19 Impact Analysis | Forecast to 2027

The global antifungal agents market is anticipated to grow at a considerable CAGR of nearly 3.5% during the forecast period (2021-2027). The factor contributing to the growth of antifungal agents include the rise in the number of COVID-19 cases and diabetic patients. Moreover, due to COVID-19, there is an increase in the number of viral infections and bacteria’s which is causing fungal infections, and patients are at high risk of healthcare-associated infections including candidemia or bloodstream infections caused by Candida. Diabetic patients are at more risk of getting affected by black fungus infection which is also known as Mucormycosis.  

To Request a Sample of our Report on Antifungal Agents Market:  https://www.omrglobal.com/request-sample/antifungal-agents-market

In addition, the companies are strategically increasing their product portfolios to grow in the market. For instance, in April 2021, Pfizer acquired Amplyx Pharmaceuticals, Inc. which is a privately-held company working in the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems.  Fosmnaogepix (APX001) is Amplyx lead compound and is a novel asset that is under development for the treatment of invasive fungal infections. Accordingly, infectious disease is responsible for more than 8.4 million mortalities annually, globally. 

Furthermore, In January 2019, Mayne Pharma Group Ltd. launched TOLSURA (SUBa - itraconazole) 65 mg capsule in the US. TOLSURA is a formulation of itraconazole for the treatment of fungal infection including blastomycosis, histoplasmosis, and aspergillosis. These infections commonly occur in immunocompromised patients such as patients with a history of cancer, transplants, and HIV/AIDS.  The company received approval for TOLSURA in 2021, from the US Food and Drug Administration (FDA). Additionally, in November 2019, SCYNEXIS, Inc. developed Ibrexafungerp for the treatment of Candida Auris and other difficult-to-treat fungal infections. Thus, the mergers & acquisitions, partnerships and collaborations and new and innovative product development in the antifungal agents are driving the growth of the market during the forecast period.

Market Coverage

·        The market number available for – 2020-2027

·        Base year- 2020

·        Forecast period- 2021-2027

Ø  Segment Covered- 

·        By Drug Class

·        By Dosage Type

·        By Route of Administration

Ø  Regions Covered-

·        North America

·        Europe

·        Asia-Pacific

·        Rest of the World

Ø  Competitive Landscape-

Key questions addressed by the report

·        What is the market growth rate?

·        Which segment and region dominate the market in the base year?

·        Which segment and region will project the fastest growth in the market?

·        How COVID-19 impacted the market?

·        Deviation from the pre-COVID-19 forecast

·        Most affected region and segment

·        Who is the leader in the market?

·        How players are addressing challenges to sustain growth?

·        Where is the investment opportunity?

 (Get 15% Discount on Buying this Report)

A full Report Antifungal Agents Market is Available at:  https://www.omrglobal.com/industry-reports/antifungal-agents-market

Global Antifungal Agents Market Segmentation

 By Drug Class 

·        Polyene

·        Echinocandins

·        Allylamines

·        Azole

By Drug Dosage 

·        Powder

·        Ointment

·        Drugs

By Route of Administration

·        Parenteral

·        Topical

·        Oral

Global Antifungal agents Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan 
  • South Korea
  • Rest of APAC

Rest of The World

  • Latin America 
  • Middle East & Africa

Company Profiles

  • Abbott Laboratories, Inc.
  • Amplyx Pharmaceuticals, Inc.
  • Astellas Pharma, Inc.
  • Basilea Pharmaceutica AG
  • Bayer Healthcare LLC
  • Bristol-Myers Squibb Pharmaceuticals, Ltd.
  • Cosmo Pharmaceuticals NV
  • Gilead Sciences, Inc.
  • Janssen Pharmaceutica NV
  • Mayne Pharma, Inc.
  • Merck & Co., Inc.
  • Mylan Pharmaceuticals, Inc.
  • Nouvasant Pharmhealth Ltd.
  • Pfizer, Inc.
  • Sanofi-Aventis U.S. LLC
  • Scynexis, Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Sun Pharmaceutical Industries, Ltd.
  • Teva Pharmaceutical Industries, Ltd.
  • Zydus Cadila Healthcare Ltd.

Reasons for Buying from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/antifungal-agents-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more